Top Pharma Companies in India 2024

The below table shows the top pharma stocks in India based on the highest market capitalization.

When it comes to investment, we tend to look for stocks that will stay relevant and perform well for an extended period. Pharmaceutical companies are stocks whose markets will always be relevant.

So this article is an effort to bring out the top pharma companies in India that have performed well in the past and look promising in the future.

You may find the analyzed lists of various factors in the article below. Keep reading to get an idea about the share market’s best pharma stocks.

Content:

• Best Pharma Stocks – 1Y Return
• Top pharma stocks in India – 1M Return
• Best Pharma Stocks in India – Daily Volume
• Best Pharma Stocks – PE Ratio
• Introduction to The Best Healthcare Stocks in India

Best Pharma Stocks

The below table shows the best pharma stocks based on 1 Year return.

Top Pharma Stocks in India

The below list has been curated upon the 1 Month return among the top pharma stocks in India.

Best Pharma Stocks in India – Daily Volume

The table below shows the best pharma stocks in India based on the highest volume.

Learn more about dividends and dividend payouts by clicking here; also, find out about the top dividend-paying companies in general.

Expanding our list of top pharma companies in India, we have also made a list of debt-free pharma stocks.

Read ahead to know more about it.

Best Pharma Stocks – PE Ratio

The table below shows the best pharma stocks based on PE Ratio.

Introduction to The Best Healthcare Stocks in India

Best Pharma Stocks – 1Y Return

Jeena Sikho Lifecare Ltd

The Market Cap of Jeena Sikho Lifecare Ltd is Rs. 2,762.71 crores. The stock’s monthly return is 1.94%. Its one-year return is 300.16%. The stock is 12.54% away from its 52-week high.

Jeena Sikho Lifecare Limited is an India-based ayurvedic healthcare company developing health care products and services. It offers a range of ayurvedic products under brands like Shuddhi, which addresses various diseases, and Origine Naturspired, focused on beauty and wellness. Key products include Shuddhi Kit, Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani Anti-Viral. The Shuddhi Kit supports digestion, immunity, hormone balance, and detoxification. The company also offers free health checkup camps and yoga sessions to raise health awareness.

Lactose (India) Ltd

The Market Cap of Lactose (India) Ltd is Rs. 234.16 crores. The stock’s monthly return is 26.53%. Its one-year return is 297.49%. The stock is 5.37% away from its 52-week high.

Lactose (India) Limited is a pharmaceutical company based in India, primarily engaged in the manufacturing and trading of pharmaceutical products. The Company specializes in producing lactose monohydrate and disaccharide lactulose. Its product range includes liquid and solid dosage forms, excipients, and active pharmaceutical ingredients. The Company manufactures dry granulated, film, and lacquer-coated tablets and produces pharma color coatings with an annual capacity of 180 metric tons. Additionally, it offers prebiotic galacto-oligosaccharides (GOS) for various applications, including dairy products, beverages, bakery items, and nutritional products. The manufacturing facility is located in Taluka Savli, Vadodara, Gujarat.

Bharat Parenterals Ltd

The Market Cap of Bharat Parenterals Ltd is Rs. 982.65 crores. The stock’s monthly return is 3.16%. Its one-year return is 274.64%. The stock is 17.35% away from its 52-week high.

Bharat Parenterals Limited is an India-based pharmaceutical company focused on manufacturing pharmaceutical formulations. The Company engages in research, development, manufacturing, marketing, sourcing, and distribution of various pharmaceutical products. Its product range includes B-lactam antibiotics, anti-retrovirals, cephalosporin antibiotics, antiprotozoals/anthelmintics, respiratory drugs, antiallergics/antihistamines/anticolds, skin infection agents, antibiotics, cardiovascular drugs, antidiabetics, antituberculosis drugs, antifungals, antimalarials, gastrointestinal drugs, anti-inflammatories/antipyretics/analgesics, supplements, central nervous system drugs, anesthetics, antivirals, steroids and hormones, uterine stimulants, and anticancer drugs.

Best Pharma Stocks – 1Y Return

Jeena Sikho Lifecare Ltd

The Market Cap of Jeena Sikho Lifecare Ltd is Rs. 2,921.07 crores. The stock’s monthly return is 6.63%. Its one-year return is 353.12%. The stock is 10.92% away from its 52-week high.

Jeena Sikho Lifecare Limited is an India-based ayurvedic healthcare company developing health care products and services. It offers a range of ayurvedic products under brands like Shuddhi, which addresses various diseases, and Origine Naturspired, focused on beauty and wellness. Key products include Shuddhi Kit, Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani Anti-Viral. The Shuddhi Kit supports digestion, immunity, hormone balance, and detoxification. The company also offers free health checkup camps and yoga sessions to raise health awareness.

Bharat Parenterals Ltd

The Market Cap of Bharat Parenterals Ltd is Rs. 848.13 crores. The stock’s monthly return is -18.68%. Its one-year return is 282.66%. The stock is 32.22% away from its 52-week high.

Bharat Parenterals Limited is an India-based pharmaceutical company specializing in the manufacturing of pharmaceutical formulations. The company is involved in research, development, manufacturing, marketing, sourcing, and distribution of a wide range of pharmaceutical products. Their product portfolio includes B-lactam antibiotics, anti-retrovirals, cephalosporins, antiprotozoals, respiratory medications, antiallergics, antibiotics, cardiovascular and anti-diabetic drugs, anti-tuberculosis and antifungal medications, antimalarials, gastrointestinal treatments, anti-inflammatories, supplements, CNS drugs, anesthetics, antivirals, steroids, hormones, uterine stimulants, and anticancer drugs. Bharat Parenterals focuses on providing comprehensive healthcare solutions through its diverse range of products.

Lactose (India) Ltd

The Market Cap of Lactose (India) Ltd is Rs. 176.56 crores. The stock’s monthly return is -2.61%. Its one-year return is 224.17%. The stock is 11.92% away from its 52-week high.

Lactose (India) Limited is a pharmaceutical company based in India, primarily engaged in the manufacturing and trading of pharmaceutical products. The Company specializes in producing lactose monohydrate and disaccharide lactulose. Its product range includes liquid and solid dosage forms, excipients, and active pharmaceutical ingredients. 

The Company manufactures dry granulated, film, and lacquer-coated tablets and produces pharma color coatings with an annual capacity of 180 metric tons. Additionally, it offers prebiotic galacto-oligosaccharides (GOS) for various applications, including dairy products, beverages, bakery items, and nutritional products. The manufacturing facility is located in Taluka Savli, Vadodara, Gujarat.

Top Pharma Stocks In India – 1M Return

Source Natural Foods and Herbal Supplements Ltd

The Market Cap of Source Natural Foods and Herbal Supplements Ltd is Rs. 105.66 crores. The stock’s monthly return is 82.39%. Its one-year return is 72.13%. The stock is 27.61% away from its 52-week high.

Source Natural Foods and Herbal Supplements Limited is an India-based company specializing in manufacturing a wide range of ayurvedic, health, dietary supplements, and food products. The company’s product segments include health care and food. The health care category offers products for ortho care, pain relief, diabetic care, digestive care, respiratory care, weight loss, mental wellness, immune modulation, natural vitamins, women’s wellness, skin care, hair and scalp health, heart care, liver care, and kidney care. The food category includes health drinks, herbal teas, health powders, masalas, spices, staples, grains, and flours. Notable products include Ojasvita beverages, various supplements like Turmeric Plus, and traditional churnas such as Sitophaladi and Triphala.

Colinz Laboratories Ltd

The Market Cap of Colinz Laboratories Ltd is Rs. 19.35 crores. The stock’s monthly return is 78.60%. Its one-year return is 124.86%. The stock is 4.26% away from its 52-week high.

Colinz Laboratories Ltd. is an India-based pharmaceutical company specializing in gynecological formulations. The company manufactures and markets a range of allopathic and ayurvedic products, including tablets, capsules, liquid orals, and ointments. It offers treatments for hypertension, cholesterol, diabetes, piles, fever, and malaria, and provides gynecologists with products for morning sickness, infertility, intrauterine growth restriction (IUGR), and pregnancy maintenance. Additionally, it offers hematinics, antispasmodics, anti-inflammatory, anti-allergic tablets, capsules, gels, and medicated shampoos. Colinz Laboratories markets its products across Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh, and West Bengal through its own marketing team.

Wockhardt Ltd

The Market Cap of Wockhardt Ltd is Rs. 13,938.01 crores. The stock’s monthly return is 56.08%. Its one-year return is 271.69%. The stock is 9.51% away from its 52-week high.

Wockhardt Limited is a pharmaceutical and biotechnology company involved in the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, APIs, and vaccines. It produces various dosage forms, including sterile injectables and lyophilized products. The company offers products in therapeutic areas such as dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough therapy, and diabetology. Notable products include Citawok, CONSEGNA, DARBOTIN, DECDAN, Emrok, Erliso, FOSCHEK-S, Gabawok NT, GLARITUS, Glimaday, INOGLA, Livatira, and VAL 450. Wockhardt has manufacturing and research facilities in India, the USA, the UK, and a manufacturing facility in Ireland.

Best Healthcare Stocks – Highest Volume

Morepen Laboratories Ltd

The Market Cap of Morepen Laboratories Ltd is Rs. 3,011.81 crores. The stock’s monthly return is 21.61%. Its one-year return is 97.71%. The stock is 2.08% away from its 52-week high.

Morepen Laboratories Ltd is an India-based pharmaceutical company specializing in the production of active pharmaceutical ingredients (APIs), formulations, and over-the-counter (OTC) products. The company manufactures and markets a wide range of healthcare products, including diagnostic devices, personal care products, and wellness solutions. Morepen has a strong presence in both domestic and international markets, exporting to over 50 countries. It is known for its flagship brand, Dr. Morepen, and its state-of-the-art manufacturing facilities comply with global regulatory standards.

Alembic Ltd

The Market Cap of Alembic Ltd is Rs. 3,087.29 crores. The stock’s monthly return is 18.45%. Its one-year return is 65.26%. The stock is 4.31% away from its 52-week high.

Alembic Limited is an India-based pharmaceutical company focused on the development, manufacturing, and marketing of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). Operating through a single Pharmaceuticals segment, Alembic specializes in fermentation and chemistry-based APIs. The company is also involved in research and development activities at its Vadodara facility. Key products manufactured by Alembic include Azithromycin, Venlafaxine, and Telmisartan. The company is committed to innovation and excellence in the pharmaceutical industry, providing high-quality products and services to meet diverse healthcare needs.

Syncom Formulations (India) Ltd

The Market Cap of Syncom Formulations (India) Ltd is Rs. 1,206.96 crores. The stock’s monthly return is 5.94%. Its one-year return is 86.67%. The stock is 35.93% away from its 52-week high.

Syncom Formulations (India) Limited is an India-based pharmaceutical company engaged in manufacturing and trading pharmaceutical drugs and formulations, as well as renting properties. The company produces a wide range of dosage forms, including tablets, capsules, liquid orals, vials, ampoule injections, dry powder injections, ophthalmic preparations, dry syrups, suspensions, ointments, creams, gels, ORS, and jelly. Syncom’s domestic product divisions include Cratus Life Care, Cratus Evolve, and Cratus Right Nutrition. Key products include Ciprofloxacin Tablets, Cefazolin, Cefotaxime, Ceftriaxone, Cefuroxime, and Gentamicin injections. The company focuses on delivering quality pharmaceutical solutions across various therapeutic areas.

Best Healthcare Stocks – PE Ratio

IND Swift Laboratories Ltd

The Market Cap of IND Swift Laboratories Ltd is Rs. 787.81 crores. The stock’s monthly return is 15.17%. Its one-year return is 56.22%. The stock is 6.11% away from its 52-week high.

Ind-Swift Laboratories Limited is an India-based company specializing in the manufacturing of intermediates and formulations. The company’s products include advanced intermediates and active pharmaceutical ingredients (APIs) for both generic and innovative domains. It offers reference standards and impurities for over 25 APIs under various pharmacopeias, including BP and EP. All impurities come with comprehensive documentation, including a Certificate of Analysis and MSDS. The company’s research center, spanning 40,000 square feet, focuses on developing process technology for APIs across different therapeutic categories.

Chemo Pharma Laboratories Ltd

The Market Cap of Chemo Pharma Laboratories Ltd is Rs. 9.99 crores. The stock’s monthly return is -3.48%. Its one-year return is 96.62%. The stock is 36.15% away from its 52-week high.

Chemo Pharma Laboratories Ltd is an India-based pharmaceutical company. The Market Cap of Chemo Pharma Laboratories Ltd is Rs. 11.63 crores. The stock’s monthly return is -18.75%. Its one-year return is 81.69%. The stock is 39.65% away from its 52-week high. The company is involved in the manufacturing and marketing of pharmaceutical products and formulations. They focus on providing a range of high-quality and cost-effective pharmaceutical solutions to various healthcare sectors.

Desh Rakshak Aushdhalaya Ltd

The Market Cap of Desh Rakshak Aushdhalaya Ltd is Rs. 4.11 crores. The stock’s monthly return is 27.02%. Its one-year return is 54.08%. The stock is 0% away from its 52-week high.

Desh Rakshak Aushdhalaya Ltd is an India-based pharmaceutical company engaged in the production and distribution of a wide range of pharmaceutical products. The Company focuses on manufacturing ayurvedic medicines and herbal formulations. Desh Rakshak Aushdhalaya offers a variety of products aimed at promoting health and wellness, including herbal tonics, dietary supplements, and traditional remedies. The Company is committed to leveraging the power of natural ingredients to provide effective and safe healthcare solutions to its customers.

Here are some of the Best Stock Research Articles listed based on Top Sectors (Industries), Market Cap, and Fundamental Analysis Factors:

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.